Adult stem cells have the potential to revolutionize regenerative medicine with their unique abilities to self-renew and differentiate into various phenotypes. This review examines progress and challenges in ex vivo tissue engineering with adult stem cells. These rare cells are harvested from a variety of tissues, including bone marrow, adipose, skeletal muscle, and placenta, and differentiate into cells of their own lineage and in some cases atypical lineages. Insight into the stem cell niche leads to the identification of matrix components, soluble factors, and physiological conditions that enhance the ex vivo amplification and differentiation of stem cells. Scaffolds composed of metals, naturally occurring materials, and synthetic polymers organize stem cells into complex spatial groupings that mimic native tissue. Cell signals from covalently bound ligands and slowly released regulatory factors in scaffolds direct stem cell fate. Future advances in stem cell biology and scaffold design will ultimately improve the efficacy of tissue substitutes as implants, in research, and as extracorporeal devices.
INTRODUCTION T
ISSUE ENGINEERING HAS BEEN DEFINED as ''an interdisciplinary field that applies the principles of engineering and the life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function.'' 1 These substitute tissues can be fabricated in situ from precursor materials by harnessing the patient's own repair mechanisms 2 or ex vivo for use as implants, in research, and as extracorporeal devices. 3 This review will focus on ex vivo engineering of living tissue substitutes, which consists of culturing cells in an in vivo-like environment that encourages growth, differentiation, and 3-dimensional (3D) organization. Growth and differentiation factors are added to culture medium 4 or introduced into cells using gene transfection 5 to simulate intercellular communication and cell signaling. Likewise, cells are encouraged to form 3D tissue within engineered scaffolds and membranes, of biological 6 or synthetic 7 origin, that resemble extracellular matrix (ECM). The net result of ex vivo tissue engineering is a living tissue substitute that mimics the differentiated structure and function of its native counterpart.
Production of engineered tissue necessitates the use of large quantities of cells, but this requirement can be difficult to satisfy with differentiated cells that exhibit limited doublings in culture. One solution to insufficient cell supplies is to prepare engineered tissue with stem cells. A characteristic feature of stem cells is to self-renew in an undifferentiated state for prolonged times while retaining the ability to differentiate along 1 lineage (unipotent), into multiple cell types (multipotent) or into cells derived from all 3 embryonic germ layers (pluripotent). 8, 9 Embryonic and adult stem cells each have advantages for therapeutic use; however, problems with teratoma formation 10 and immune rejection 11 must be overcome before pluripotent embryonic stem cells will be practical for therapeutic use. Unipotent and multipotent adult stem cells have been isolated from a variety of tissues and function in vivo to maintain healthy tissue (homeostasis) and to repair damaged tissue. 12 The benefits of using adult instead of embryonic stem cells to prepare living tissue substitutes include immuno-compatibility of autologous cells, ease of inducing differentiation to a specific lineage, and availability. 13 Although adult stem cells have the potential to divide and regenerate tissue throughout an entire human lifetime in vivo, they do not proliferate and differentiate as effectively ex vivo.
14 Effectively replicating the stem-cell microenvironment or ''niche'' could allow adult stem cells to more fully reach their regenerative potential during tissue engineering.
Much progress has been made recently in tissue engineering with adult stem cells, particularly in preclinical research, on the cell source for tissue substitutes, ex vivo amplification and differentiation, and 3D tissue organization, but there are still many engineering and biological challenges ahead. The entry of more tissue engineers into stem cell research will accelerate further advances. This review is written to aid tissue engineers in this transition by describing the accomplishments in the field thus far, identifying limitations in current technology, and discussing how insight into stem cell biology can guide tissue-engineering efforts in the future.
CELL SOURCE

Tissue location
Multipotent adult stem cells have been found in many tissues, including bone marrow, 15 adipose, 16 skeletal muscle, 17 cerebral cortex, 18 olfactory bulb core, 19 placenta, 20 gastric epithelium, 21 retina, 22 inner ear, 23 and hair follicle bulge. 24 These cells are rare; the frequency of human retinal stem cells is 1 in 500, 22 and pluripotent bone marrow cells may be as rare as 1 in 10 7 to 10 8 . 25 In addition, the concentration of stem cells and partially differentiated progenitor cells in tissue can be highly variable. The osteogenic progenitor quantity in human bone marrow aspirates differs significantly between donors and even between aspirates from the same donor. 26 Another variable in the availability of stem cells is donor age. The number of osteogenic progenitors in bone marrow decreases from 66.2 AE 9.6 per 10 6 cells for donors younger than 40 years of age to 14.7 AE 2.6 per 10 6 cells for older donors. 27 Similarly, the number 28 and proliferation potential 29 of muscle satellite cells decline with age. Ironically, this means that the elderly, who would benefit from stem-cell technology to regenerate aged tissues, may often be the people least able to produce harvestable stem cells.
Bone marrow, which is well characterized because of its historical use in post-radiation transplantation, 30 has been a popular source of adult stem cells for tissue engineering. A second, more recently described, source of multipotent cells is processed lipoaspirate cells from adipose tissue. 16 Aspirates from either source can be harvested during routine elective medical procedures 16, 31 and, because of their mesenchymal origin, have been used to engineer such tissues as cartilage, 32 bone, 33 adipose, 34 and blood vessels, 35 as described in Table 1 . One difference between adipose tissue-and marrow-derived multipotent cells is their expression of adhesion molecules. Bone marrow stromal cells (BMSCs) exhibit greater expression of vascular cell adhesion molecule-1 and less expression of alpha 4 integrin and intercellular adhesion molecule-1 than those from adipose tissue. 36 These adhesion molecules have all been implicated in stem cell mobilization and homing, suggesting that adipose tissue-and marrow-derived multipotent cells may have different homing properties to distant tissue. In addition to cells of mesodermal origin like marrow and adipose tissue, stem cells from the other 2 embryonic germ layers, ectoderm and endoderm, have also been successfully used to engineer tissues (Table 1) . Human ectodermal stem cells from micro-grafted hair follicles have been used clinically to repopulate a dermal template for burned skin replacement. 37 Another example of ectodermal stem cell engineering is rat neural stem and progenitor cells differentiating into functional neuronal circuits in a 3D collagen gel, with the potential to repair injury to the central nervous system. 38 Endodermal stem cells differentiate into many of the internal organs, such as the liver, lung, and pancreas, and have been used, for example, to generate b-like cell colonies that increase insulin secretion in response to glucose. 39 
Surface markers
One of the first challenges of using stem cells for tissue engineering is their isolation. Stem cells are defined by their behavior, not by any molecules or structures they contain, and a definitive set of surface markers that can clearly distinguish between a stem cell and its differentiated neighbors has yet to be identified. 40 Also, hematopoietic stem cells (HSCs) adhere to certain osteoblastic cells, and an increase in the number of osteoblastic cells correlates to an increase in the number of HSCs. 41 This suggests that stem cells within their niche are found adjacent to other types of cells and that the maintenance of their stem-like properties may depend on adhesion to non-stem cells. Because of these difficulties, schemes to separate stem cells from differentiated cells based on surface markers have not been entirely successful. Nevertheless, surface markers can be used to remove most of the contaminating cells from a population. BMSCs were first isolated using plastic adherence and presence of the STRO-1 antigen. 42 Since then, a wide variety of surface markers have been suggested to select for BMSCs, 43 including positive selection for CD29 (integrin beta 1), CD44 (phosphoglycoprotein-1), CD90
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(Thy-1), and CD105 (endoglin), and negative selection for hematopoietic markers CD34 and CD45. 36, 44, 45 BMSCs have also been isolated based on their light-scattering properties. 46 Primitive long-term murine HSCs can be separated from less-potent short-term HSCs by the absence of the Flk-2 receptor tyrosine kinase. 47 In ectodermal tissues, rat neural stem cells have been separated from mature neurons based on CD56, a neural cell-adhesion molecule found on the surface of mature neurons, and CD57, a carbohydrate epitope expressed by neural stem cells. 48 Human keratinocyte stem cells have been isolated on the basis of expressing large amounts of alpha 6 integrin combined with lack of transferrin receptor (CD71). 49 Stem cells from endodermal tissues have not been studied as thoroughly as those from ectodermal and mesodermal tissues. Aquaporin-3 (AQP3) water channel has been recently identified as a marker to separate human basal progenitors of the airway epithelium from ciliated and secretory cells. 50 It is likely that AQP3þ cells are heterogeneous and that identification of more surface markers will be necessary to isolate the stem cell fraction.
Plasticity
Under certain circumstances, it would be desirable to harvest autologous stem cells from tissue other than the targeted tissue to be regenerated, when, for instance, the targeted tissue is diseased or when extraction would cause irreversible trauma to the brain or other critical organs. If tissue engineers can harness the therapeutic potential of stem cell plasticity, then stem cells could be harvested from a far greater variety of autologous tissues than is currently possible. Plasticity is the ability of stem cells to differentiate across the embryonic germ line boundaries of mesoderm, ectoderm, and endoderm. The existence of plasticity has, however, been debated heavily in the past several years. It has been suggested that apparent plasticity can be attributed to population heterogeneity or to cell fusion events. However, clonally derived multipotent adult progenitor cells from mouse and rat bone marrow have been differentiated in vitro into cells from all 3 germ layers without undergoing cell fusion. 15 Cloned cells have also been transdifferentiated in coculture systems, where fusion events can be detected by marking the two cell types with different fluorescent compounds 51 or by measuring deoxyribonucleic acid (DNA) ploidy. 52 These techniques show that single BMSCs can differentiate into airway epithelial cells and neural cells without undergoing cell fusion. One explanation for this phenomenon is that adult stem cells are suspended in a state of promiscuous gene expression (Table 2) , 53 with DNA helicases promoting an open chromatin structure 54 that makes many genes available for transcription. The 15, 51 If the yield can be standardized, control over stem cell plasticity and gene promiscuity may mean that cell sources can be chosen, based not on the tissue to be generated but on ease of stem cell extraction and amplification.
EX VIVO AMPLIFICATION AND DIFFFERENTIATION
Regenerative capacity
Understanding and harnessing the stem cell's inherent ability to create self-replicates and differentiated progeny is a major challenge in tissue engineering. Although in vivo stem cells have the potential to divide and repair tissue throughout an entire human lifetime, the regenerative capacity of adult stem cells is, for the most part, more limited when expanded in monolayer culture. Human BMSCs in monolayer cultures can lose the ability to differentiate into adipocytes by passage 12, 14 murine neural progenitor cells begin to lose the ability to differentiate into striatal projection neurons after just one passage, 56 and late-passage porcine BMSCs exhibit loss of multi-potency along with signs of cellular aging such as actin accumulation and reduced substrate adherence. 57 Loss of differentiation capacity and senescence may be partly due to dilution of multi-potent stem cells by partially differentiated progeny during asymmetric cell division. 58 A strategy to address the dilution effect may be to induce symmetric, selfrenewing cell divisions. Culturing rat hepatic stem cells in the presence of the purine nucleoside xanthosine, which promotes guanine ribonucleotide formation via salvage pathways, reversibly converts the cells to symmetric division without exhibiting senescence or tumorigenicity. 59 Another mechanism for loss of multi-potency is that culture medium may select for one subset of stem cells at the expense of others, leading to inability to differentiate along specific lineages after prolonged culture. 57 A third mechanism involves shortening of telomeres, a natural cellular aging process. Telomere length, which decreases sharply with ex vivo expansion of BMSCs, 60 is typically thought of with respect to replicative senescence, but it has an effect on differentiation as well. Deficiency of the telomere-extending enzyme telomerase inhibits murine BMSC differentiation into adipocytes and chondrocytes even at early passage, 61 whereas overexpression of telomerase reverse transcriptase is sufficient to maintain multi-potency of human BMSCs for more than 3 years in culture. 62 One possible mechanism for this telomeraseenhanced differentiation capacity is resistance to oxidative stress. Stem cells with elevated telomerase activity accumulate fewer peroxides than wild-type cells. 63 More evidence for the link between oxidative stress and reduced differentiation capacity comes from the fact that culturing human BMSCs in hypoxic conditions causes the cells to express telomerase and replicate past the Hayflick limit of 50 population doublings without loss of multipotency. 64 
Cultivation strategies
Insight into the surrounding microenvironment in the stem cell niche can guide engineering efforts to direct stem cell fate. Contact with neighboring cells in the niche can be simulated with coculture techniques. Proliferation-enhancing feeder layers for human cells include human BMSCs for early progenitor cells from umbilical cord blood, 65 growth-arrested human dermal fibroblasts for hair follicle stem cells, 66 and the murine stromal cell line AFT024 for multi-potent hematopoietic progenitors. 67 Neighboring cells can also direct differentiation; coculture with heat-shocked small airway epithelial cells causes human BMSCs to differentiate into airway epithelial-like cells. 68 Adherens junctions between murine HSCs and neighboring niche cells may have a role in intercellular communication in addition to cell adhesion. 41 The quantity of a stem cell's neighbors can be as important as their identity; stem cells are routinely maintained in subconfluent cultures to avoid spontaneous differentiation upon confluence. To mimic cell-matrix interactions, culture dishes can be coated with matrix components. Collagen type I supports the long-term colony-forming ability of mouse liver progenitors, 69 laminin-5 causes osteogenic differentiation in human BMSCs, 70 and fibronectin inhibits differentiation of human adipose stem cells and progenitors. 71 Physiological factors, including oxygen tension and pH, are also relevant in the stem cell environment. Modeling suggests that the bone marrow hematopoietic compartment is hypoxic, with notable oxygen gradients. 72 The importance of reduced oxygen tension for the ex vivo amplification of hematopoietic stem cells has long been recognized, 73 and cultures maintained at 1% oxygen are able to preserve the marrow-repopulating ability of murine HSCs while encouraging expansion of progenitors. 74 Similarly, rat BMSCs cultivated at 5% oxygen instead of 20% oxygen exhibit more rapid proliferation and greater expression of key markers of osteogenesis such as alkaline phosphatase activity and calcium content. 75 A high pH of 7.6 promotes the maturation and apoptosis of human megakaryocytic cells better than physiological conditions do, 76 whereas a subvascular pH of 7.07 to 7.21 enhances granulopoiesis proliferation better than pH 7.38.
77
Elucidating the identities and functions of soluble factors that influence stem cell fate would provide a beneficial assortment of biochemicals to use in constructing living tissue substitutes. Endothelial cells stimulate murine neural stem cell self-renewal even when a Transwell membrane separates the 2 cell types, 78 and medium conditioned using human stromal cells supports hematopoiesis. 79 These experiments demonstrate that paracrine signaling molecules can alter stem cell fate. Injured tissue also releases soluble factors that TISSUE ENGINEERING WITH ADULT STEM CELLS trigger stem cell mobilization and proliferation. For example, osteopontin, a secreted glycoprotein involved in inflammation, stimulates proliferation of putative stem cells harvested from human prostate epithelium, 80 and unknown soluble factors released by bleomycin-injured mouse lung cells cause BMSCs to proliferate and migrate toward the injured tissue. 81 Circulating endothelial progenitor cells (EPCs) home into ischemic tissue and engraft to vascularize the tissue in response to the chemokine stromal cell-derived factor-1.
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Proliferation can also occur as a result of differentiationinducing agents, as when adipogenic agents stimulate clonal expansion of murine adipose progenitors. 83 The signaling molecules that promote proliferation can depend on age; human cord blood stem cells and adult HSCs require different cytokines for optimal amplification. 84 A variety of biochemical cocktails have been developed that differentiate adult stem cells to a particular lineage within their own germ line. Mesenchymal cells are induced to the osteogenic lineage with dexamethasone, ascorbic acid-2-phosphate, and beta-glycerophosphate; 85 the chondrogenic lineage with transforming growth factor beta 2 (TGF-b2) and -b3 in a micro-mass culture; 86 the adipogenic lineage with insulin, dexamethasone, and methylisobutylxanthine; 83 and the myogenic lineage with 5-azacytidine. 87 TGF-b1 causes ovine EPCs from peripheral blood to differentiate to a smooth muscle-like phenotype, 88 and murine neural crest stem cells from hair follicles can be differentiated into Schwann cells with neuregulin-1. 89 Less is known about what is necessary to induce trans-differentiation across germ layer boundaries. Human adipose tissue-derived stem cells, of mesodermal origin, differentiate into early neural progenitors in the presence of isobutyl methylxanthine, indomethacin, and insulin. 90 Still less is known about the signaling molecules that are involved within the niche in vivo and whether these will prove to be useful for engineering. Vascular endothelial growth factor-A is one such molecule that functions as an autocrine signaling molecule in human BMSCs during osteogenic differentiation. 91 Further research into the signaling that occurs in vivo may lead to a much greater ability to control stem cell fate.
THREE-DIMENSIONAL ORGANIZATION
Scaffolds
Stem cells exist in vivo in complex 3D groupings with neighboring cells. 41 Initiating 3D assembly can be as simple as aggregating cells under centrifugal force to create a micromass culture. In the presence of soluble chondrogenic inducers, for example, a micro-mass of human BMSCs forms cartilage. 4 Generally, though, exogenous materials are used to guide the 3D organization of stem cells in engineered tissues, as illustrated in Figure 1 . Scaffolds made of metals like titanium are bio-compatible and suitable for hard-tissue applications, such as the growth and differentiation of rat dental pulp progenitor cells into odontoblast-like cells. 7 To improve their efficacy, metal scaffolds can be covered with biological compounds, like titanium fibers pre-coated with ECM components that support the osteogenic differentiation of rat BMSCs. 92 A second class of scaffolds is naturally occurring organic materials that provide a bio-mimetic environment for stem cells. Human BMSCs regenerate bone in marine sponge skeletons, 93 cartilage in silk fibroin scaffolds, 94 and adipose tissue in gelatin. 95 In addition to providing mechanical strength, natural scaffolds can contain biological agents that influence stem cell fate; marine sponge skeletons, for example, contain the cell adhesion proteins fibronectin and tenascin. 93 In contrast to naturally occurring materials, synthetic polymers provide greater control over the mechanical and degradation properties of the tissue scaffold. Selfassembling peptide scaffolds are composed of highly flexible nano-fibers that support the differentiation of putative rat liver progenitor cells into functional hepatocyte-like spheroinods. 96 Block copolymers of poly (e-caprolactone) and poly(ethylene glycol) promote human and rat BMSC attachment, proliferation, and ECM production, whereas the polymer scaffold degrades over the period of 60 weeks. 97 Ligand binding and controlled release of regulatory factors can improve the degree of control over spatial organization and differentiation of stem cells within scaffolds. Covalently bound ligands interact with cell surface receptors, as in the case of neural progenitor cells in a peptide scaffold presenting the neurite-promoting laminin epitope isoleucine-lysine-valine-alanine-valine (IKVAV). The cells undergo more-rapid differentiation into neurons than when plated on laminin or exposed to a soluble form of IKVAV. 98 For osteogenic differentiation, incorporating peptides containing the cell-binding sequence arginine-glycine-aspartate into an oligo(poly(ethylene glycol) fumarate) scaffold allows rat BMSCs to differentiate in the absence of soluble factors like dexamethasone. 33 Controlled release of regulatory molecules from scaffolds increases the duration of cell exposure to these agents. For instance, osteogenic differentiation agents like ascorbate-2-phosphate and dexamethasone are released from a porous poly(D,L-lactideco-glycolide) scaffold over the course of 35 days, causing rabbit BMSCs within the scaffold to mineralize in vitro into bone. 99 The slow release of the cholesterol-lowering drug simvastatin from degrading poly(lactide-co-glycolide) promotes bone mineralization of rat BMSCs more effectively than when the drug is dissolved in culture medium or even released by passive diffusion from scaffolds. 100 Advanced manufacturing techniques can be used to control the spatial architecture in engineered tissues, manipulating the scaffold topography on the length scale of the stem cell niche and smaller. Fused deposition modeling allows for the creation of computer-designed poly (caprolactone)/calcium phosphate scaffolds with honeycomblike 300-to 500-mm pores. Relative to conventional processing techniques that leave a thin polymer layer covering the calcium phosphate particles, fused deposition modeling results in direct cell contact to the particles, enhancing human BMSC adhesion, migration, and osteogenic differentiation. 101 Retinal applications, in which the in vivo architecture is complex and multilayered, underscore the importance of controlling a scaffold's pore structure. Porous poly(L-lactic acid) and poly(lactic-co-glycolic acid) scaffolds with 100-to 200-mm pores oriented normal to the plane of the scaffold cause murine retinal progenitor cells to adhere and align with the scaffold, re-creating the polarized organization of photoreceptors. 102 In addition to controlling the gross porous structure, it is possible to imprint fine patterns into the surface of a scaffold. Femtosecond laser ablation produces micropatterns of niche-like groves in collagen scaffolds that trap and support the growth of rat BMSCs. 103 Similarly, microcontact printing, together with chemical patterning, creates neurochips of poly(dimethylsiloxane) with hydrophilic wells and hydrophobic ridges that direct the attachment and proliferation of neural progenitor cells. 104 Electro-spun fibers are an alternative to porous and imprinted scaffolds. A nanofibrous scaffold composed of poly (e-caprolactone) forms an artificial ECM that resembles collagen fibers in its ability to support the differentiation of human BMSCs along adipogenic, chondrogenic, and osteogenic lineages. 105 Moreover, electro-spinning can be used to generate poly(L-lactic acid) scaffolds with aligned nano-scale fibers that direct spatial adhesion of murine neural stem cells and the orientation of neurite outgrowth upon differentiation. 106 
Mechanical forces
Once stem cells have been embedded in a 3D scaffold, mechanical forces can stimulate spatial organization and differentiation, mimicking cues the cells receive in vivo. In hyaluronan-gelatin scaffolds, human BMSCs in the presence of chondrogenic medium show greater cartilaginous matrix formation when the scaffolds are subjected to cyclic mechanical compression than do uncompressed samples. 107 For rabbit BMSCs, cyclic compression is as effective as TGF-b1 at inducing chondrogenic differentiation. 108 Just as compression enhances chondrogenesis, stretching stimulates ligament and muscle formation. Mechanical stretching of a collagen gel containing human or bovine BMSCs causes the stem cells to exhibit an elongated morphology akin to that of native ligament without the addition of exogenous growth and differentiation factors to culture medium. 109 Similarly, human mesenchymal stem cells embedded in a collagen gel form a wavy orientated tissue containing ligament-like ECM when subjected to cyclic stretching. 110 Stem cells can distinguish between different types of mechanical stretching. Uniaxial stretching transiently enhances the expression of smooth muscle markers like smooth muscle a-actin in human BMSCs, whereas equilateral stretching inhibits smooth muscle differentiation. 111 
Vascularization
Ex vivo engineering with EPCs has the potential to improve the survival of living tissue substitutes upon implantation. 112 EPCs and their differentiated progeny assemble ex vivo into a rudimentary 3D vasculature that may expedite the delivery of oxygen and other nutrients to implanted tissue. Fluid flow stimulates human peripheral blood EPCs to form capillarylike tubes and an extensive tubular network in collagen gels significantly faster than in static controls. 113 Instead of directly seeding EPCs into a scaffold, the cells can be differentiated before inoculation, as in the case EPC-derived endothelial cells seeded onto preformed tubular scaffolds of polyglycolic-acid and polyurethane. 114 Coculture 35 A vascularized tracheal implant has been constructed ex vivo using porcine chondrocytes, respiratory epithelial cells, smooth muscle cells, and EPCs seeded onto a scaffold of acellularized porcine small intestine. Three weeks after inoculation, EPCs uniformly re-endothelialized the vascular network within the scaffold. 115 
FUTURE DIRECTIONS
Tremendous progress has been made in understanding and harnessing the tissue-regenerating properties of stem cells. At present, though, many challenges remain before stem cell-based constructs will be available for therapeutic use. Subsequent achievements in this field will be attained through a greater understanding of stem cell biology at the molecular level and engineering advances in scaffold design with micro-and nano-scale technology.
Fundamental discoveries that elucidate the molecular mechanism of stem cell self-renewal and differentiation will aid the tissue engineer in harvesting stem cells, retaining their regenerative capacity, and directing their fate. The rarity of adult stem cells necessitates the identification of easily identified characteristics, like surface markers or dye efflux rate, 116 that clearly distinguish stem cells and progenitors from mature cells in tissue. The loss of the regenerative capacity of stem cells during ex vivo amplification is another obstacle to overcome. Culture conditions that more closely mimic cell-cell and cell-matrix interactions in the stem cell niche will likely retain the proliferative and differentiation capacity of stem cells for longer periods of time. 117 There is only rudimentary knowledge of the biological cues in vivo that direct stem cell fate. Further insight into receptor-ligand interactions will be helpful in directing fate decisions between self-renewal and differentiation along a specific lineage. 118 When autologous stem cells are not readily available, it would be desirable to harvest stem cells from an allogeneic source. Tissues created from allogeneic stem cells, however, present a unique challenge with respect to immune rejection. For allogeneic constructs to be feasible, immunosuppressive therapies are under development to induce a state of immune tolerance, including transfecting stem cells with human cytomegalovirus unique short stealth genes 119 and co-transplantation of immunoregulatory T cells. 120 Scaffold design and construction is another area in which further innovations will be necessary to bring stem cell-based constructs to the clinic. Although EPC-based vascularized scaffolds improve tissue survival after implantation, 121 precise control over oxygen supply will be necessary, both during ex vivo tissue assembly and after implantation, to emulate the mildly hypoxic conditions under which stem cells survive and proliferate. Beyond oxygen supply, the location and concentration of fate-directing molecules must be controlled. Scaffolds containing signals that promote organized differentiation into multiple cell types could allow engineered tissue to mimic complex native structures containing multiple layers like stroma and epithelium. Moreover, patterns of fate-controlling signals could be used to create a self-healing tissue replacement that contains undifferentiated cells for tissue maintenance and repair in addition to functionally differentiated cells. Attaining this level of detail in scaffold design will require innovations in micro-and nano-scale technology, using fabrication techniques like layer-by-layer stereolithography 122 and laser-guided direct writing 123 to produce bio-mimetic configurations of cells and cell signals. Ultimately these techniques will produce scaffolds that more closely imitate the stem cell environment in the niche and during homeostasis and tissue repair in terms of spatial architecture and the temporal pattern of cell signals.
The remarkable progress in the development of tissue substitutes with adult stem cells foretells the future success of their clinical application. By highlighting achievements and limitations in the field, this review may aid tissue engineers in formulating research strategies to address the challenges that remain and ultimately to realize the therapeutic potential of stem cells. Interdisciplinary collaborations may be helpful in this regard by allowing researchers to combine current knowledge about stem cell biology with state-of-the-art technology to synthesize functional tissue substitutes with the desired mechanical and biological properties. Together, advances in these scientific and technological areas will improve the variety and efficacy of living tissue substitutes.
